Cellular Physiology of Rat Cardiac Myocytes in Cardiac Fibrosis: In Vitro Simulation Using the Cardiac Myocyte/Cardiac Non-Myocyte Co-Culture System

An understanding of the cellular physiology of cardiac myocytes (MCs) and non-myocytes (NMCs) may help to explain the mechanisms underlying cardiac hypertrophy. Despite numerous studies using MC/NMC co-culture systems, it is difficult to precisely evaluate the influence of each cell type because of the inherent cellular heterogeneity of such a system. Here we developed a co-culture system using Wistar rat neonatal MCs and NMCs isolated by discontinuous Percoll gradient and adhesion separation methods and cultured on either side of insert well membranes. Co-culture of MCs and NMCs resulted in significant increases in [3H]-leucine incorporation by MCs, in the amount of protein synthesized by MCs, and in the secretion of natriuretic peptides, while the addition of MCs to NMC cultures significantly reduced [3H]-thymidine incorporation by NMCs. Interestingly, the percentage of the brain natriuretic peptide (BNP) component of total natriuretic peptide secreted (atrial natriuretic peptide+BNP) increased as the number of NMCs placed in the MC/NMC co-culture system increased. However, MCs did not affect production of angiotensin II (Ang II) by NMCs or secretion of endothelin-1 and transforming growth factor-β1 into the MC/NMC co-culture system. This finding was supported by the anti-hypertrophic and anti-fibrotic actions of RNH6270, an active form of olmesartan, on MCs in the MC/NMC co-culture system and on NMCs that may synthesize Ang II in the heart. The present data indicate that cardiac fibrosis may not only facilitate MC hypertrophy (possibly through the local angiotensin system) but may also change particular pathophysiological properties of MCs, such as the secretory pattern of natriuretic peptides.

[1]  H. Koike,et al.  Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. , 1995, European journal of pharmacology.

[2]  K. Pandey Biology of natriuretic peptides and their receptors , 2005, Peptides.

[3]  N. Schneiderman,et al.  Cardiovascular responsivity to stress in adolescents with and without persistently elevated blood pressure , 2001, Journal of hypertension.

[4]  M. Matthay,et al.  Fluid transport across cultured rat alveolar epithelial cells: a novel in vitro system. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[5]  S. Brandt,et al.  Microgenomics: gene expression analysis at the tissue-specific and single-cell levels. , 2005, Journal of experimental botany.

[6]  M. Peppelenbosch,et al.  Single cell proteomics for personalised medicine. , 2004, Trends in molecular medicine.

[7]  J. Saris,et al.  Prorenin uptake in the heart: a prerequisite for local angiotensin generation? , 2002, Journal of molecular and cellular cardiology.

[8]  L R Schwocho,et al.  Pharmacokinetics of CS‐866, a New Angiotensin II Receptor Blocker, in Healthy Subjects , 2001, Journal of clinical pharmacology.

[9]  K. Nakao,et al.  Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes , 2005, Peptides.

[10]  H. Drexler,et al.  The renin-angiotensin system and experimental heart failure. , 1999, Cardiovascular research.

[11]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[12]  K. Nakao,et al.  Possible involvement of endothelin-1 in cardioprotective effects of benidipine. , 2000, Hypertension research : official journal of the Japanese Society of Hypertension.

[13]  Y. Matsui,et al.  A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[14]  J. Burnett,et al.  Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases , 2002, Circulation research.

[15]  T. Igaki,et al.  Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. , 1997, Circulation.

[16]  Andrew D McCulloch,et al.  Microstructured Cocultures of Cardiac Myocytes and Fibroblasts: A Two-Dimensional In Vitro Model of Cardiac Tissue , 2005, Microscopy and Microanalysis.

[17]  N. Kobayashi,et al.  Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats. , 2002, European journal of pharmacology.

[18]  F. Park,et al.  Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. , 1999, American journal of physiology. Renal physiology.

[19]  V. Regitz-Zagrosek,et al.  Neutral Endopeptidase Is Activated in Cardiomyocytes in Human Aortic Valve Stenosis and Heart Failure , 2002, Circulation.

[20]  H. Itoh,et al.  Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. , 1998, Journal of cardiovascular pharmacology.

[21]  C. Reutelingsperger,et al.  Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy , 2004, Molecular and Cellular Biochemistry.

[22]  W. Kirch,et al.  The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction , 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[23]  T. Maki,et al.  Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. , 2003, Endocrinology.

[24]  V. Cameron,et al.  Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. , 2000, Endocrinology.

[25]  K. Nakao,et al.  5-hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. , 2005, Biochemical and biophysical research communications.

[26]  R. Zak Cell proliferation during cardiac growth. , 1973, The American journal of cardiology.

[27]  K. Flanders,et al.  Autoinduction of mRNA and protein expression for transforming growth factor-beta S in cultured cardiac cells. , 1995, Journal of molecular and cellular cardiology.

[28]  A. Richards,et al.  Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. , 2000, The Journal of endocrinology.